Roemer Alan S.
Insider CIK 1643070 · NEXI Director · INAB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INAB IN8BIO, INC. | A Award | 2025-12-22 | 2025-12-23 | 36,232 | $1.38 | $50.0K | 49,514 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2025-05-08 | 2025-05-12 | 63,150 | — | $0 | 63,150 | SEC↗ |
| INAB IN8BIO, INC. | M Exercise deriv | 2025-04-30 | 2025-05-07 | 102,459 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | M Exercise deriv | 2025-04-30 | 2025-05-07 | 11,000 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | M Exercise | 2025-04-30 | 2025-05-07 | 102,459 | $0.18 | $18.4K | 387,489 | SEC↗ |
| INAB IN8BIO, INC. | M Exercise | 2025-04-30 | 2025-05-07 | 11,000 | $0.18 | $2.0K | 398,489 | SEC↗ |
| INAB IN8BIO, INC. | D To issuer deriv | 2025-04-27 | 2025-05-07 | 102,459 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2025-04-27 | 2025-05-07 | 102,459 | — | $0 | 102,459 | SEC↗ |
| INAB IN8BIO, INC. | D To issuer deriv | 2025-04-27 | 2025-05-07 | 102,459 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2025-04-27 | 2025-05-07 | 11,000 | — | $0 | 11,000 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2025-04-27 | 2025-05-07 | 91,459 | — | $0 | 91,459 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2024-12-19 | 2024-12-23 | 93,242 | — | $0 | 93,242 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2024-10-04 | 2024-10-08 | 126,582 | — | $0 | 126,582 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2024-10-04 | 2024-10-08 | 102,459 | — | $0 | 102,459 | SEC↗ |
| INAB IN8BIO, INC. | D To issuer deriv | 2024-10-04 | 2024-10-08 | 102,459 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | A Award | 2024-10-04 | 2024-10-08 | 126,582 | — | $0 | 285,030 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2024-06-12 | 2024-06-14 | 33,650 | — | $0 | 33,650 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2023-12-13 | 2023-12-15 | 102,459 | — | $0 | 102,459 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2023-12-13 | 2023-12-15 | 102,459 | — | $0 | 102,459 | SEC↗ |
| INAB IN8BIO, INC. | A Award | 2023-12-13 | 2023-12-15 | 102,459 | — | $0 | 158,448 | SEC↗ |
| NEXI NexImmune, Inc. | S Sale | 2023-11-22 | 2023-11-22 | 3,992 | $1.94 | $7.7K | 0 | SEC↗ |
| NEXI NexImmune, Inc. | S Sale | 2023-11-21 | 2023-11-22 | 3,833 | $2.16 | $8.3K | 3,992 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2023-07-05 | 2023-07-07 | 44,983 | — | $0 | 44,983 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2023-06-15 | 2023-06-16 | 85,000 | — | $0 | 85,000 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 9,556 | — | $0 | 9,556 | SEC↗ |
| NEXI NexImmune, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-06 | 9,556 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 61,678 | — | $0 | 61,678 | SEC↗ |
| NEXI NexImmune, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-06 | 23,122 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 23,122 | — | $0 | 23,122 | SEC↗ |
| NEXI NexImmune, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-06 | 3,856 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 3,856 | — | $0 | 3,856 | SEC↗ |
| NEXI NexImmune, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-06 | 61,678 | — | $0 | 0 | SEC↗ |
| INAB IN8BIO, INC. | P Buy | 2022-08-16 | 2022-08-18 | 26,315 | $1.90 | $50.0K | 55,989 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 61,678 | — | $0 | 61,678 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2022-06-01 | 2022-09-23 | 13,500 | — | $0 | 13,500 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2022-06-01 | 2022-06-14 | 10,500 | — | $0 | 10,500 | SEC↗ |
| NEXI NexImmune, Inc. | M Exercise deriv | 2021-12-21 | 2021-12-22 | 42,389 | — | $0 | 3,856 | SEC↗ |
| NEXI NexImmune, Inc. | M Exercise deriv | 2021-12-21 | 2021-12-22 | 12,634 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | M Exercise deriv | 2021-12-21 | 2021-12-22 | 12,634 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | M Exercise | 2021-12-21 | 2021-12-22 | 12,634 | $2.58 | $32.6K | 153,252 | SEC↗ |
| NEXI NexImmune, Inc. | M Exercise | 2021-12-21 | 2021-12-22 | 12,634 | $2.42 | $30.6K | 140,618 | SEC↗ |
| NEXI NexImmune, Inc. | M Exercise | 2021-12-21 | 2021-12-22 | 42,389 | $4.31 | $182.7K | 195,641 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2021-11-19 | 2021-11-23 | 86,258 | — | $0 | 86,258 | SEC↗ |
| INAB IN8BIO, INC. | A Award deriv | 2021-07-29 | 2021-08-02 | 10,500 | — | $0 | 10,500 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 0 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 85,016 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 4,110 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 26,590 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 12,268 | — | $0 | 127,984 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 85,016 | — | $0 | 85,016 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 26,590 | — | $0 | 115,716 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 4,110 | — | $0 | 89,126 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2021-02-11 | 2021-02-16 | 9,556 | — | $0 | 104,191 | SEC↗ |